HNRNPA1 and gastric cancer: Apart from indicating that among the six SFs, HNRNPA1, but not HNRNPA1 mRNA, is the most clinically applicable marker for GC, our results offer new insight into the expression profiles and diagnostic efficacies of the six SFs in GC that is required for their future practical implementations.